AstraZeneca and
Lilly to
test new
cancer drug combination
LONDON (Reuters) -
AstraZeneca and Eli
Lilly are to combine two of their
cancer ***** in a new clinical trial against solid tumors in the latest sign that such cocktails may be the way forward in fighting the disease.
